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With the aim of developing stimuli-responsive imaging agents, we report here the synthesis of core 
crosslinked star (CCS) polymers and their evaluation as pH-sensitive 19F magnetic resonance imaging 
(19F MRI) contrast agents. Block copolymers consisting of poly(ethylene glycol) methyl ether 
methacrylate (PPEGMA) as the first block and a copolymer of 2-(dimethylamino)ethyl methacrylate 
(DMAEMA) and 2,2,2-trifluoroethyl methacrylate (TFEMA) as the second block  were synthesised using 10 
RAFT polymerisation. The polymerisation kinetics were studied in detail. The block copolymers were 
then used as arm precursors for the arm-first synthesis of CCS polymers through RAFT dispersion 
polymerisation. The synthetic conditions were investigated and optimised. CCS polymers with a 
degradable core were also synthesised and evaluated as 19F MRI contrast agents. The degradation of the 
core was confirmed by treatment with various reducing agents. The particle size, 19F NMR signal and 15 
relaxation times as well as 19F MRI imaging performance of the CCS polymers were studied at a range of 
value of solution pH. Significant enhancement of the image intensity was observed when the pH was 
decreased from 8 to 5, indicating that the CCS nanoparticles could be used as 19F MRI contrast agents for 
the detection of the acidic environment within tumour tissue.      
Introduction 20 
Magnetic resonance imaging (MRI), a commonly-used diagnostic 
modality, has proven to be an indispensable imaging technique 
since its first appearance in the early 1970s. Unlike other imaging 
procedures, in particular X-ray computed tomography (CT), MRI 
does not utilise ionizing radiation during image acquisition, and is 25 
therefore non-harmful to humans. 1H MRI in particular can 
provide spatial anatomical images with high quality and 
resolution, with contrast arising from differences in proton 
density and relaxation parameters. However, 1H MRI is 
intrinsically restricted by two factors. First, the abundant water 30 
molecules in the body generate strong background signals that 
make detection of small concentrations of particular tissue types 
or metabolites difficult. Secondly, the proton relaxation times in 
different tissues are often similar, resulting in poor image 
contrast.1 To address these issues, tremendous efforts have been 35 
devoted to the development of 1H MRI contrast agents. The 
principle classes of 1H MRI contrast agents include gadolinium-
based chelates,2-4 superparamagnetic iron oxide nanoparticles,5, 6 
manganese-based contrast agents,7-11 and other lanthanide-based 
contrast agents.12, 13 An alternative approach to improving image 40 
contrast is to consider other NMR-active nuclei, and 19F MRI has 
been considered to be an excellent option.  
 
 
 45 
 
 
Australian Institute for Bioengineering and Nanotechnology and Centre 
for Advanced Imaging, The University of Queensland, St Lucia, 4072, 
Australia. E-mail: a.whittaker@uq.edu.au; Fax: +61-7-33463973; Tel: 50 
+61-7-33463885 
† Electronic Supplementary Information (ESI) available: [GPC, DLS and 
NMR results]. See DOI: 10.1039/b000000x/ 
   
 55 
 Shortly after the appearance of 1H MRI, the first example of 19F 
MRI was reported in 1977.14 Compared to other candidates, such 
as 13C, 15N and 31P, the 19F nucleus exhibits a number of attractive 
properties, e.g. 100% natural abundance, high sensitivity (83% 
relative to 1H), large gyromagnetic ratio (40.03 MHz/T, 94% 60 
relative to 1H), and absence in the human body.15-17 The 
physiological rarity of mobile fluorine nuclei in the body 
guarantees essentially no background signal during imaging and 
highlights the distinctive advantage of 19F MRI. 19F MRI 
naturally relies on the use of 19F-containing contrast agents, and a 65 
high concentration of 19F nuclei is preferred in the target voxel to 
provide adequate signal for the acquisition of good quality 
images. During the past few decades, perfluorocarbons (PFCs) 
have been extensively exploited as 19F MRI contrast agents 
because of their high fluorine content as well as chemical and 70 
biological inertness.17-19 Due to their hydrophobicity, PFCs are 
normally formulated as emulsions for biological applications. 
Although a few PFCs emulsion are commercially available for 
clinical use, this category of contrast agents has several 
drawbacks, such as emulsion stability, limited methods of 75 
functionalization and long reticuloendothelial system clearance 
times.20-22 
  Recently, 19F MRI contrast agents based on polymers have been 
introduced by a number of groups. Several classes of polymeric 
agents have been developed and evaluated, including linear 80 
polymers,23-28 hyperbranched polymers,29, 30 dendrimers31-34 and 
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nanogels.35 In our previous studies, we suggested that polymeric 
19F MRI agents should fulfil a list of criteria, i.e. high fluorine 
content, separation of fluorine segments, small particle size, low 
cytotoxicity and possibility for chemical modification of 
conjugation.24, 25, 30 We are particularly interested in polymeric 5 
contrast agents that have highly-branched structures because 
these polymers have the potential to fulfil the aforementioned 
requirements. In these molecules, a high concentration of highly 
separated fluorine segments retains high flexibility, resulting in 
efficient averaging of the dipolar coupling and therefore ensures 10 
strong signal intensity in 19F MRI. On the other hand, the 
abundant functional groups in the polymers are especially 
favourable for  
Scheme 1 Schematic illustration of the synthesis of CCS polymers15 
subsequent functionalization for specific applications. 
 
  In recent years ‘smart’ imaging agents, which are responsive to 
certain environmental conditions (pH, temperature, light, ionic 
strength, the presence of enzymes, redox potential, etc.), have 20 
elicited great scientific interest.36-42 In particular it is well known 
that compared to normal tissues, cancerous tissues have a slightly 
acidic extracellular pH (6.7-7.1),43 hence it has been suggested 
that they may be detected through selective imaging using 
contrast agents that can be triggered by a change in pH. The 25 
development of pH-responsive imaging agents has become an 
intensive research field, and a variety of such imaging agents 
have been fabricated and show great potential for the early 
diagnosis of cancer diseases.34, 44-50. 
  Core crosslinked (CCS) star polymers, which are composed of a 30 
number of arms and a crosslinker core, have a spherical 3D 
structure and possess unique properties. In the past several years, 
CCS star polymers synthesised by reversible-deactivation radical 
polymerization (also referred to as controlled radical 
polymerisation) via the arm-first approach have been studied in 35 
detail.51 Synthesis of CCS polymers via the arm-first method 
allows for the precise pre-design of arm precursors and can thus 
lead to star polymers with well-defined structures and 
compositions. In our previous study, star polymers with a 
branched core (composed of 19F-containing and pH-responsive 40 
units) and hydrophilic arms were prepared and utilised as 
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selective 19F MRI contrast agents with the potential for the 
detection of diseased tissues.52 Although branched polymers 
bearing 19F nuclei have been developed as 19F MRI contrast 
agents, to the best of our knowledge, CCS polymers with 
fluorinated units in the arms have not been reported as 19F MRI 5 
agents. In this paper we investigate the effect of placement of 19F 
nuclei and pH-responsive units in the block copolymer arms 
instead of in the branched core.      
  In this paper, we aim to synthesise core crosslinked star (CCS) 
polymers as 19F MRI contrast agents via the arm-first approach 10 
by reversible addition-fragmentation chain transfer (RAFT) 
polymerisation. As illustrated in Scheme 1, the arms are block 
copolymers that contain 2,2,2-trifluoroethyl methacrylate 
(TFEMA) units to provide 19F NMR and MRI signal and 2-
(dimethylamino)ethyl methacrylate (DMAEMA) segments to 15 
achieve pH-responsiveness. In addition, the cores are comprised 
of bis(2-methacryloyl)oxyethyl disulfide (DSDMA) crosslinked 
homopolymer, which is degradable in the presence of reducing 
agents. It is expected that the protonation and deprotonation of 
DMAEMA units in the copolymer arms in aqueous solution will 20 
not only influence the size of the nanoparticles but also alter the 
mobility of 19F nuclei in the TFEMA segments, resulting in the 
variations in signal intensity and relaxation times of 19F nuclei 
with pH. Moreover, selective imaging can be realised in 19F MRI 
by utilising the pH-responsiveness of the 19F relaxation times. 25 
Last but not least, since the CCS polymers have abundant 
disulfide bonds in the crosslinked core, the as-formed 
nanoparticles can be degraded by reducing agents such as 
dithiothreitol (DTT), tris(2-carboxyethyl)phosphine 
hydrochloride (TCEP) and glutathione (GSH),53-55 and this 30 
biodegradability is especially desirable for future in vivo 
applications.  
Experimental Section 
Materials 
All chemicals were purchased from Sigma-Aldrich unless 35 
otherwise stated. Poly(ethylene glycol) methyl ether methacrylate 
(PEGMA, MW = 475), 2-(dimethylamino)ethyl methacrylate 
(DMAEMA), 2,2,2-trifluoroethyl methacrylate (TFEMA), 
ethylene glycol dimethacrylate (EGDMA), butyl methacrylate 
(BMA) and 2-hydroxyethyl methacrylate (HEMA) were passed 40 
through basic alumina columns to remove inhibitors prior to use. 
The initiators, 2,2’-azobis(2-methylpropionitrile) (AIBN) and 
4,4’-azobis(4-cyanovaleric acid) (ACVA) were recrystallised 
from ethanol twice before use. 4-Methoxyphenol (MEHQ), 4-
(dimethylamino)pyridine (DMAP), triethylamine (TEA), N,N’-45 
dicyclohexylcarbodiimide (DCC),  tris(2-carboxyethyl)phosphine 
hydrochloride (TCEP) and L-glutathione reduced (GSH) were 
used as received. The trithiocarbonate RAFT agent, 4-cyano-4-
(dodecylsulfanylthiocarbonyl)sulfanyl pentanoic acid (denoted as 
CTA), was synthesised following a previously reported method.56 50 
Milli-Q water with a resistivity of 18.4 MΩ.cm-1 was used for the 
synthesis and purification of polymers and preparation of aqueous 
solutions. Tetrahydrofuran (THF), dichloromethane (DCM) and 
toluene were obtained from a solvent purification system (SPS) 
and used directly. 55 
Characterisation 
  Gel Permeation Chromatography (GPC) Molecular weights 
and molecular weight distributions were determined by GPC 
using a Waters Alliance 2690 Separations Module equipped with 
Waters 2414 Refractive Index (RI) Detector, Waters 2489 60 
UV/Visible Detector, Waters 717 Plus Autosampler and Waters 
1515 Isocratic HPLC Pump. Samples were dissolved in 
THF/triethylamine (95/5, v/v) and passed through 0.45 µm filters 
before each measurement. THF was used as the mobile phase at a 
flow rate of 1 mL/min. The system was calibrated using 65 
polystyrene (PS) standards, to which the number average 
molecular weight (Mn) and weight average molecular weight 
(Mw) were referenced. Absolute molecular weights of the star 
polymers were measured by a triple detection GPC (Polymer 
Labs GPC50) equipped with dual angle laser light scattering 70 
detector, viscometer and differential refractive index detector. 
N,N-dimethylacetamide (DMAc, HPLC grade, containing 0.03 
wt % LiCl) was used as the eluent at a flow rate of 1.0 mL min-1. 
Separations were achieved using two PLGel Mixed B (7.8 × 300 
mm) columns connected in series and held at a constant 75 
temperature of 50 oC. The triple detection system was calibrated 
using a 2 mg mL-1 PSTY standard (Polymer Laboratories, Mw = 
110 K, dn/dc = 0.16 mL g-1 and IV = 0.5809). Samples of given 
concentrations were prepared in DMAc (containing 0.03 wt% 
LiCl) and passed through a 0.45 μm PTFE syringe filters prior to 80 
measurements. The absolute molecular weights and dn/dc values 
were determined by using Polymer Laboratories Multi Cirrus 
software based on the quantitative mass recovery technique.  
  Nuclear Magnetic Resonance (NMR) 1H NMR and 13C NMR 
analysis were performed on a Bruker Avance 500 MHz 85 
spectrometer equipped with a  BBO5 probe at 25 oC using an 
internal lock (CDCl3) and referenced to the residual non-
deuterated solvent (CHCl3). 
  Dynamic Light Scattering (DLS) DLS measurements were 
carried out on a Nanoseries Zetasizer (Malvern, UK) at 25 oC. 90 
Sample solutions were prepared in PBS (1 mg/mL) at different 
pH values and passed through 0.45 µm filters prior to each 
measurement. Each hydrodynamic diameter was the average 
value of 5 runs. To minimise the influence of large aggregates, 
number averaged diameters are reported.  95 
 19F Nuclear Magnetic Resonance (19F NMR) All 19F NMR 
spectra were acquired at 470.55 MHz without 1H decoupling on a 
Bruker  Avance 500 spectrometer using a 5 mm broadband 
inverse probe (BBO5) for which the inner coil was double-tuned 
for 19F and 1H. The samples were prepared by dissolving the star 100 
polymers in PBS/D2O (90/10, v/v) at a concentration of 20 
mg/mL. All measurements were performed at 25 oC. A 90o pulse 
of 15.1 µs was used in all measurements, the relaxation delay was 
2 s and the acquisition time was 0.7 s. Data were collected using 
a spectrum width of 23 kHz, 32k data points and 128 scans. 105 
  19F spin-spin relaxation times (T2) were measured using the 
Carr-Purcell-Meiboom-Gill (CPMG) pulse sequence at 25 oC. 
The samples were dissolved in PBS/D2O (90/10, v/v) at a 
concentration of 20 mg/mL. The relaxation delay was 3 s and the 
acquisition time was 0.7 s. For each measurement, the echo times 110 
were from 2 to 770 ms and 15 points were collected, which could 
be described by exponential functions for the calculation of T2.  
  19F spin-lattice (T1) relaxation times were measured using the 
standard inversion-recovery pulse sequence. For each 
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measurement, the recovery times were from 2 ms to 3 s and 15 
points were acquired. Values for the major peak at around -72.6 
ppm are reported. 
  19F Magnetic Resonance imaging (19F MRI) 
Images of phantoms containing the solutions of the CSS particles 5 
were acquired on a Bruker BioSpec 94/30 USR 9.4 T small 
animal MRI scanner.  CCS polymers were dissolved in PBS/D2O 
(90/10,v/v) to a concentration of 20 mg/mL and placed in a 
1H/19F dual resonator 40 mm volume coil. 1H were acquired for 
localisation of the samples using a RARE sequence with an echo 10 
train length of 8 (TE = 28 ms, TR = 2 s, FOV = 40 × 40 × 1 mm, 
Matrix = 128 × 128 × 1).  19F images were acquired in the same 
stereotactic space as the 1H image using a RARE sequence with 
an echo train length of 8 (TE = 10 ms, effective TE = 40 ms, TR 
= 1 s, FOV = 40 × 40 × 30 mm, Matrix = 32 × 32 × 1) with a total 15 
acquisition time of 1 hour 8 minutes. 
Synthesis of alkyne-terminated chain transfer agent (alkyne-
CTA) 
The CTA (4.04 g, 10 mmol), propargyl alcohol (1.46 mL, 25 
mmol) and DMAP (0.24 g, 2 mmol) were dissolved in 130 mL of 20 
DCM in a 250 mL flask, which was sealed with a rubber septum 
and then bubbled with argon for 30 min in an ice bath. Following 
this, DCC (4.13 g, 20 mmol) in 20 mL of DCM was injected 
dropwise into the flask. The reaction was kept in the ice bath and 
magnetically stirred for 2 h, followed by stirring at room 25 
temperature for 48 h. After the reaction, the mixture was filtered 
to remove the insoluble dicyclohexylurea precipitate. The filtrate 
was washed with water (100 mL × 2) and brine (100 mL × 2), 
and then dried over anhydrous MgSO4. Finally, the solvent was 
removed by rotary evaporation, and the residual oil was further 30 
purified by flash column chromatography (SiO2, gradient 
petroleum spirit/ethyl acetate, from 9/1 to 8/2), yielding a scarlet 
oil (3.7 g, 84% yield). 
  1H NMR (500 MHz, δ, ppm, CDCl3): 0.88 (t, 3H, CH3CH2CH2), 
1.26 (br s, 18H, (CH2)9), 1.69 (m, 2H, CH2CH2S), 1.87 (s, 3H, 35 
CH3), 2.37-2.70 (m, 4H, CH2CH2-COO), 2.49 (t, H, 
OCH2C≡CH), 3.32 (t, 3H, CH2CH2S), 4.70 (d, 2H, OCH2C≡CH).       
  13C NMR (125 MHz, δ, ppm, CDCl3): 170.63 (COOCH2), 
118.87 (CN), 75.20 (C≡CH), 52.41(C≡CH), 46.21 (C(CH3)CN)), 
37.03 (C(=O)CH2CH2), 33.62 (C(=O)CH2CH2), 31.85, 29.56, 40 
27.61, 24.81, 22.63 (overlapping 13C signals), 14.07 
(CH3CH2CH2). 
Synthesis of poly PPEGMA macro-CTA 
PEGMA (24 g, 50 mmol), alkyne-CTA (0.886 g, 2 mmol), AIBN 
(66 mg, 0.4 mmol) were dissolved in 50 mL of toluene in a 100 45 
mL flask, which was sealed with a rubber septum and bubbled 
with argon for 1 h in an ice bath. Then the flask was immersed in 
an oil bath maintained at 70 oC and magnetically stirred. At given 
intervals, samples were withdrawn using a gas-tight syringe for 
measurement of extent of conversion. After 180 min, the 50 
polymerisation was quenched by cooling the flask in an ice bath 
and exposing the solution to air. The crude solution was 
precipitated into cold hexane 3 times and then dialysed against 
water for 2 days. After lyophilisation, a yellow oil was obtained. 
Yield: 11 g, 94%). GPC: Mn = 7200, molar mass dispersity (ĐM, 55 
Mw/Mn) = 1.12. 1H NMR: DP = 14, Mn = 7100. 
Synthesis of PPEGMA-b-P(TFEMA-co-DMAEMA) block 
copolymers 
In a typical experiment, the macro-CTA (0.665 g, 0.094 mmol), 
TFEMA (0.144 mL, 1 mmol), DMAEMA (0.674 mL, 4 mmol) 60 
and AIBN (3.3 mg, 0.02 mmol) were dissolved in 4 mL of 
toluene. The solution was equally divided into 5 tubes, each of 
which was purged with nitrogen for 5 min in an ice bath before 
being placed in a 70 oC oil bath. The tubes were opened and 
cooled to 0 oC at various time intervals to allow measurement of 65 
conversion.  
  For the fully scaled-up synthesis, the macro-CTA (3.6 g, 0.51 
mmol), TFEMA (0.771 mL, 5.4 mmol), DMAEMA (3.649 mL, 
21.6 mmol) and AIBN (17.8 mg, 0.102 mmol) were dissolved  in 
22 mL of toluene in a 100 mL flask, which was sealed with a 70 
rubber septum and purged with nitrogen for 30 min in an ice bath. 
The flask was placed in a 70 oC oil bath for 2.5 h, followed by 
being cooled to 0 oC and exposed to air.  The sample was purified 
by precipitation into cold hexane 3 times and dried under 
vacuum. A yellowish viscous solid was obtained. Yield: 4.86 g, 75 
86%. The degree of polymerisation (DP) was calculated from 1H 
NMR, and the composition of the block copolymer was 
confirmed to be PPEGMA14-b-(TFEMA5-co-DMAEMA19) 
(10500 by 1H NMR), ĐM= 1.21 (by GPC).  
Synthesis of CCS polymers using EGDMA as crosslinker 80 
CCS polymers were synthesised by the arm-first approach 
through dispersion polymerisation. Typically, PPEGMA14-b-
(TFEMA5-co-DMAEMA19) (0.210 g, 0.02 mmol), BMA (16 µL, 
0.1 mmol), EGDMA (20 mg, 0.1 mmol) and ACVA (1.12 mg, 
0.004 mmol) were added to a mixture of 2 mL ethanol and 2 mL 85 
water. The solution was stirred at room temperature for 30 min to 
form a clear solution, before being divided into 5 tubes 
containing stirrer bars. Each tube was sealed with a rubber 
septum, followed by being purged with nitrogen for 15 min in an 
ice bath. After that, the tubes were immersed in 70 oC oil bath, 90 
and were opened at given time intervals for GPC and DLS 
analysis.  
Synthesis of bis(2-methacryloyl)oxyethyl disulfide (DSDMA) 
Degradable crosslinker DSDMA was synthesised using a 
published procedure,57 with minor modification. 2-Hydroxyethyl 95 
disulfide (7.7 g, 0.05 mol) and MEHQ (60 mg) were added to 150 
mL DCM in a 500 mL flask, and a heterogeneous mixture was 
formed. Then methacryloyl chloride (20 mL, 0.2 mol) was added 
to the mixture. The flask was immersed in an ice/water bath and 
TEA was added drop-wise using a dropping funnel over 40 min. 100 
During addition of the TEA, a white precipitate was gradually 
formed. After the addition of TEA, the mixture was stirred at 0 oC 
for another 30 min and then at room temperature for 24 h. After 
reaction, the mixture was filtered to remove the the insoluble 
triethylamine hydrochloride salt. Then the filtrate was washed 105 
with 1 M NaHCO3 solution (150 mL × 3) and water (150 mL × 
3), and the organic phase was dried over anhydrous MgSO4 with 
60 mg of MEHQ. After that, DCM was removed by rotary 
evaporation. The residual was purified by flash column 
chromatography (SiO2, gradient hexane/ethyl acetate, from 90/10 110 
to 60/40). A slightly yellowish oil was obtained and was stored in 
a freezer in dark. Yield: 8.9 g, 61%. 
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Synthesis of biodegradable CCS polymers using DSDMA as 
crosslinker 
PPEGMA14-b-(TFEMA6-co-DMAEMA20) (0.216 g, 0.02 mmol), 
DSDMA (58 mg, 0.2 mmol) and ACVA (2.24 mg, 0.005 mmol) 
were added to a mixture of 2 mL ethanol and 2 mL water, which 5 
was then stirred at room temperature for 30 min to form a clear 
solution.  After that the solution was divided equally to 4 tubes, 
and each tube was purged with nitrogen for 10 min in an ice bath. 
Finally the tubes were placed in a 70 oC oil bath, and each tube 
was opened and cooled to 0 oC periodically.  GPC measurements 10 
were carried out for each sample to monitor the formation of CCS 
polymer. 
  For the scale-up synthesis, PPEGMA14-b-(TFEMA6-co-
DMAEMA20) (2.16 g, 0.2 mmol), DSDMA (0.58 g, 2 mmol) and 
ACVA (22.4 mg, 0.05 mmol) were added to a mixture of 20 mL 15 
ethanol and 20 mL water in a 100 mL flask, which was then 
sealed with a rubber septum and purged with nitrogen for 45 in an 
ice bath. Then the flask was immersed in 70 oC oil bath for 30 
min. After polymerisation, the sample was purified using 
centrifugal filter units (Amicon Ultra-15, 100k) and then 20 
lyophilised.  
Degradation of star polymer by reduction with TCEP 
SP-1 (30 mg, 4.6× 10-5 mmol) was dissolved in 6 mL of methanol 
in a 20 mL schlenk tube, which was then magnetically stirred and 
purged with Ar. After 30 min, TCEP (86 mg, 0.3 mmol) was 25 
added to the polymer solution under the protection of Ar. The 
solution was stirred at RT for 7 hours, followed by the injection 
of pre-deoxygenated TEA (100 µL, 0.72 mmol) and MMA (200 
µL, 1.87 mmol) to cap the formed thiol groups. After stirring at 
RT overnight, the reaction was stopped through exposure to air 30 
and an aliquot was withdrawn for GPC analysis. 
Degradation of star polymer by reduction with GSH 
SP-1 (15 mg, 2.3 × 10-5 mmol) was dissolved in 30 mL of PBS in 
a 100 mL flask and the pH was adjusted to 7.4 using 1 M NaOH 
solution. The flask was then sealed with a rubber septum and 35 
purged with Ar for 30 min, followed by the addition of GSH (92 
mg, 0.3 mmol) under Ar flow. The solution was purged with Ar 
for another 30 min and stirred at 37 oC. After 72 h, pre 
deoxygenated TEA (200 µL, 1.44 mmol) and HEMA (250 µL, 
2.06 mmol) were injected to the flask to cap the thiol groups that 40 
were formed after reduction. After another 24 h the sample was 
freeze dried and subjected to GPC analysis. 
 45 
Fig. 1 RAFT polymerisation of TFEMA and DMAEMA using PPEGMA 
macro-CTA. (A) Pseudo-first-order kinetic plots of the polymerisation. 
(B) Dependence of number-average molecular weight (Mn, determined by 
GPC) and molar-mass dispersity (ĐM) on the total monomer conversion. 
(C) GPC traces during the polymerisation. 50 
 
 
 
 
Table 1 Properties of the macro-CTA and arm precursors. 55 
 
a Weight percentage of fluorine in the samples. b Mn and ĐM acquired by 
GPC RI detector. c Mn calculated using the DP given by 1H NMR. 
Results and Discussion 
Synthesis of PPEGMA macro-CTA 60 
A trithiocarbonate chain transfer agent, 4-cyano-4-
(dodecylsulfanylthiocarbonyl)sulfanyl pentanoic acid, was first 
end functionalised with propargyl alcohol and subsequently used 
for the synthesis of PPEGMA macro-CTA, as reported in our 
previous study.52 The alkyne end group can offer the possibility 65 
of further modification of the CCS polymer through ‘click’ 
Sample 19Fa 
wt% 
Mnb 
(GPC) 
ĐM
b Mnc 
(1H NMR) 
Macro-CTA (PPEGMA14) - 7200 1.12 7100 
Arm-1 
(PPEGMA14-b-(TFEMA5-co-
DMAEMA19) 
3.2 9200 1.24 10500 
Arm-2 
(PPEGMA14-b-(TFEMA11-co-
DMAEMA15) 
5.5 8900 1.20 11300 
Arm-3 
(PPEGMA14-b-(TFEMA18-co-
DMAEMA10) 
8.8 8900 1.18 11700 
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chemistry. Furthermore, the alkyne end group facilitates the 
calculation of the degree of polymerisation (DP) using 1H NMR 
owing to the well-resolved peak (~4.7 ppm) due to the protons in 
the methylene group adjacent to the alkyne group. PEGMA was 
chosen because of its hydrophilicity and biocompatibility. The 5 
kinetics of the synthesis of PPEGMA was investigated, and the 
results confirmed a well-controlled RAFT polymerisation (Fig. 
S1, ESI†). The PPEGMA so-formed (DP = 14, Mn (1H NMR) = 
7100, ĐM = 1.12) was used as the macro-CTA in subsequent 
steps.  10 
Synthesis of PPEGMA-b-P(TFEMA-co-DMAEMA) block 
copolymers 
The as-synthesised PPEGMA macro-CTA was chain extended 
with TFEMA and DMAEMA for the synthesis of PPEGMA-b-
P(TFEMA-co-DMAEMA). As displayed in Fig. 1, the 15 
polymerisation rates of both TFEMA and DMAEMA exhibited 
pseudo-first-order kinetics throughout the polymerisation to 
above 80% conversion (Fig. 1 (A)). In addition, the number-
average molecular weight increased linearly with monomer 
conversion while the molar-mass dispersity (ĐM) remained 20 
relatively low (Fig. 1 (B)). Furthermore, the GPC curves also 
evolved from long retention time to short retention time with 
increase of reaction time and conversion (Fig. 1 (C)). This 
confirms the successful synthesis of PPEGMA-b-P(TFEMA-co-
DMAEMA) from the PPEGMA macro-CTA. To minimise the 25 
loss of trithiocarbonate end group, a monomer conversion of 
~50% was targeted in the scale-up polymerisation. After 
purification, PPEGMA14-b-(TFEMA5-co-DMAEMA19) was 
obtained (denoted as Arm-1, Mn = 10500 by 1H NMR, ĐM = 
1.21). In order to prepare block copolymers with different 30 
compositions, Arm-2 (PPEGMA14-b-(TFEMA11-co-DMAEMA15, 
Mn = 11300 by 1H NMR, ĐM = 1.20) and Arm-3 (PPEGMA14-b-
(TFEMA18-co-DMAEMA10, Mn = 11700 by 1H NMR, ĐM = 
1.18) were then synthesised by adjusting the  
TFEMA/DMAEMA ratio and using the same polymerisation 35 
condition. The properties of the macro-CTA and block 
copolymers are summarised in Table 1. 
 
  40 
Fig. 2 GPC traces during the synthesis of CCS polymer using EGDMA as 
crosslinker by dispersion polymerisation. Condition: [Arm-
1]/[BMA]/[EGDMA]/[ACVA] = 1/5/5/0.2, [arm-1] = 5 mM, in 
water/ethanol (50/50, v/v), 70 oC. 
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Synthesis of CCS polymers through RAFT dispersion 
polymerisation by the arm-first approach 
Recently, RAFT dispersion polymerisation has been exploited for 
the synthesis of CCS polymers by the An group and its benefits 
have been discussed and highlighted.58-61 Compared to 50 
conventional homogeneous polymerisation in organic solvents, 
the heterogeneous polymerisation in aqueous solution can 
significantly reduce the polymerisation time due to an accelerated 
monomer consumption. Furthermore, the method can increase the 
yield of star polymer by facilitating the arm incorporation 55 
process. As the three block copolymers were all water soluble 
due to the hydrophilic PPEGMA segments, RAFT dispersion 
polymerisation in water/ethanol mixture was introduced for the 
synthesis of CCS polymers. 
  The CCS polymers were synthesised through the chain 60 
extension of arm precursors with the crosslinker EGDMA. The 
polymerisation was carried out in water/ethanol mixture (50/50, 
v/v) at 70 oC using ACVA as initiator. It was found that the 
polymerisation time played a pivotal role in the formation of CCS 
polymers. Fig. 2 shows the GPC traces of the samples withdrawn 65 
at different polymerisation times during the dispersion 
polymerisation. As one can see in Fig. 2 (A), although the peak in 
the traces due to the arms became broader and started to shift 
toward shorter retention times, no well-defined CCS polymer was 
formed within 20 min. After 30 min, a peak appeared at retention 70 
time of 14.6 min and could be assigned to the CCS polymer. Over 
the next 30 min the intensity of the CCS peak continued to rise 
while that of the linear polymer peak at 16.2~17.0 decreased 
gradually, indicating increasing arm incorporation and yield of 
CCS polymer. Interestingly, as shown in Fig. 2 (B), the intensity 75 
of the CCS polymer peak decreased by half after 2 hours, and 
then continued to be diminished over the next 4 hours before it 
completely disappeared after 8 hours. 
  Based on the GPC traces, the extent of formation of the CCS 
polymer through the chain extension of block copolymer with 80 
crosslinker reached a maximum after 1 hour. However, due to 
monomer consumption and abundant vinyl groups in the core, 
after 1 hour intermolecular coupling (or star-star coupling) started 
to dominate the polymerisation, and resulted in the formation of 
 This journal is © The Royal Society of Chemistry [year] Journal Name, [year], [vol], 00–00  |  7 
macroscopic gel particles, which consumed the as-formed CCS 
polymers and substantially reduced the CCS polymer yield. In 
support of this a digital photo of the samples at increasing 
conversion demonstrates a change from clear solution to turbid 
dispersion (Fig. S2, ESI†), confirming the gradual formation of 5 
larger, insoluble particles after 1 hour.  Furthermore, the particle 
size (number averaged diameter) of the crude polymerisation 
solution increased significantly from 7.4 nm after 10 minutes to 
13.4 nm after 1 hour, slowly increased to 14.8 nm after 6 hours 
before dramatically increasing to ~360 nm after 8 hours (Fig. S3, 10 
ESI†). After filtration, the particle size became smaller owing to 
the removal of large particles (Fig. S3, ESI†).  
  A number of other significant parameters in the polymerisation 
were also investigated. It was found that the water/ethanol ratio 
was a key factor since well-defined CCS polymer were only 15 
formed in water/ethanol (50/50, v/v) (Fig. S4 (A), ESI†). This is 
understandable since a higher ethanol content in the 
polymerisation solvent (> 75 %) will result in homogeneous 
polymerisation; CCS polymers usually take much longer to form 
(typically 8~24 h) in organic solvents62-65 than dispersion 20 
polymerisation. However, the arm precursor has poor solubility 
when the ethanol content is too low (< 50 %). Therefore a 
moderate water/ethanol ratio is required for a successful 
dispersion polymerisation, so that the starting reagents dissolve 
well while the CCS polymer has poor solubility. In addition, 25 
unlike other reports,59, 60, 62 the use of the spacing monomer did 
not improve the formation of CCS polymer. Moreover, the 
highest yield of CCS polymers was achieved when 
[EGDMA]/[arm-1] ratio was 10 or 15 (Fig. S4 (C), ESI†). As 
shown in ESI† Fig. S4 (D), the CCS polymer yield was also 30 
increased by using a higher [ACVA]/[Arm-1] ratio (2/5). These 
results revealed that the arm-first synthesis of CCS polymer via 
RAFT dispersion polymerisation could be affected by a number 
of parameters and well-defined CCS polymers with high yield 
could be obtained by carefully selecting and controlling the 35 
polymerisation conditions.         
  A degradable crosslinker, bis(2-methacryloyl)oxyethyl disulfide 
(DSDMA), was then chosen for the synthesis the CCS polymers. 
As displayed in Fig. 3 (A), well-defined CCS polymer can be 
synthesised within 30 min with the highest yield (74%). At longer 40 
reaction times star-star coupling became more important, as 
evidenced by the decrease in the peak in the GPC traces due to 
the CCS polymer. The as-synthesised CCS polymer (denoted as 
CCS-1) was purified using centrifugal filter units. In Fig. 3 (B), 
one can see that most of the linear residues were removed after 45 
purification (black line). The polymers in the filtrate (denoted as 
Filtrate-1) were also collected and examined by GPC and 1H 
NMR. According to the GPC trace (green line), despite the 
presence of a small amount of CCS polymer (1.21%), the linear 
residues showed a smaller Mn compared to that of Arm-1while its 50 
ĐM was as low as that of Arm-1. In addition in the 1H NMR, as 
shown in ESI† Fig. S5 (B), for Filtrate-1, the peak intensity of the 
protons of the CH2 next to the trithiocarbonate considerably 
decreased compared with Arm-1, suggesting that the residual 
linear polymers had very low end group functionality. The 55 
structure of the residual polymer was confirmed to be 
PPEGMA14-b-P(TFEMA3-co-DMAEMA8) by 1H NMR with Mn 
of 8400. We therefore conclude that the residual linear polymer 
collected from the filtrate is block copolymer in which the 
trithiocarbonate end groups have been lost during the synthesis of 60 
the arm precursor.  
 
 
Fig. 3 GPC traces of CCS polymer synthesised using DSDMA as 65 
crosslinker. (A) GPC traces at different polymerisation time. (B) GPC 
traces of CCS polymer prepared after 30 min. Condition: [Arm-
1]/[DSDMA]/[ACVA] = 1/10/0.4, [arm-1] = 5 mM, in water/ethanol 
(50/50, v/v), 70 oC. 
 70 
  In the 1H NMR spectrum of CCS-1 (Fig. S5 (C), ESI†) peaks at 
5.6 and 6 ppm were assigned to the unreacted vinyl groups that 
were likely to be in the periphery of the core. Nevertheless, the 
DSDMA units could not be fully detected due to the highly rigid 
nature of the core.66 The 13C NMR spectrum (Fig. S5 (D), ESI†) 75 
further confirmed the absence of a peak at ~222 ppm due to the 
trithiocarbonate carbons.  It is well known that the increased 
dipolar couplings experienced in rigid cores of particles may 
prevent direct observation by solution-state NMR methods.  
 80 
Table 2 Details of the CCS polymers. 
Sample 19F wt% Mn 
(GPC) 
ĐM Absolute 
MW 
ĐM f 
CCS-1 2.3 32800 1.23 653,300 1.17 46 
CCS-2 3.9 43300 1.19 482,500 1.07 31 
CCS-3 6.1 28000 1.19 683,000 1.15 41 
a Fluorine content in the samples. b Mn and ĐM of crude CCS polymers 
given by GPC RI detector. c Absolute MW and ĐM measured by triple 
detection GPC. d Number of arms (see the calculation in ESI†) 
 85 
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  Fig. 4 Number averaged diameter of CCS-1 in PBS (1 mg/mL) at 
different pH at 25 oC. 
 
  A range of CSS polymers with different compositions were 5 
prepared by using Arm-2 and Arm-3 for the synthesis of CCS-2 
and CCS-3, respectively, and the resulting CCS polymers were 
purified using the same procedure described above for CCS-1. 
The properties of the CCS polymers are listed in Table 2. 
  The particle sizes of CCS-1 in PBS and at a range of pH values 10 
from 4 to 9 were measured by DLS. As shown in Fig. 4, the 
particle size was around 23 nm when the pH was below 6.5 and 
decreased progressively with an increase in pH and finally 
reached ~18 nm at pH 9. The change in particle size arises from 
the DMAEMA units present in the arms; PDMAEMA is well 15 
known as a pH-responsive polymer and has a pKa between 
7.3~7.5. Specifically, in aqueous solution, the protonation of the 
tertiary amines below pKa renders the PDMAEMA segments 
charged and the chains undergo electrostatic repulsion, while on 
deprotonation above pKa the chains adopt a more contracted 20 
configuration. On the basis of the DLS results, the volume of 
CCS-1 nanoparticles at pH 9 was reduced by 53% compared to 
that at pH 5, indicating a significant dependence of particle size 
on environmental pH. 
 25 
 
 
 
 
 30 
 
 
 
Fig. 5 GPC traces of CCS-1 before and after degradation by TCEP (A) 
and GSH (B), respectively 35 
 
 
Degradation of CCS polymer  
Disulfide-containing crosslinkers have been frequently used for 
the preparation of degradable materials because the disulfide 40 
group can be cleaved to thiols by reducing agents.67 As the core 
of the as-synthesised CCS polymer is comprised of PDSDMA 
homopolymer, it is expected that the core can be degraded when 
treated with reducing agents. The degradation of CCS-1 in 
methanol was first tested using TCEP as the reducing agent, and 45 
the GPC curve shifted to longer retention time after 7 hours while 
the ĐM was as low as that of Arm-1 (Fig. 5 (A)), confirming the 
successful cleavage of the disulfide bonds in the core. It should 
be noted that the thiol groups in solution are very sensitive to 
oxygen and can form disulfide again when exposed to air. For 50 
example, after reduction of the CCS-1 with DTT in THF, samples 
were withdrawn periodically for GPC analysis, and the GPC 
curves of the degraded polymer shifted progressively to longer 
retention time and the ĐM became very large (39~98) owing to 
the re-formation of disulfide linkages in air (Fig. S7, ESI†). To 55 
avoid the re-formation of disulfides, after degradation the thiol 
groups were capped with MMA through based-catalysed Michael 
addition.68, 69 
  Since TCEP is not physiologically available, glutathione (GSH) 
was then chosen for the degradation of CCS-1. It has been 60 
reported that GSH is present in the human body at micromolar 
concentrations in blood plasma, ~10 mM in the cytosol 53, 70  and 
at several times higher concentration in tumour cells than normal 
cells.71, 72 As shown in Fig. 5 (B), two peaks appeared after 
degradation with TCEP. To be more specific, the major peak with 65 
Mn of 8700 was from the linear polymers after the degradation of 
the crosslinked core, while the minor peak with Mn of 74100 was 
caused by the re-formation of disulfide groups due to the 
incomplete degradation of the core. As the core was comprised of 
hydrophobic PDSDMA that was poorly accessible for water and 70 
the GSH concentration was also relatively low, we propose that 
the degradation of CCS-1 using 10 mM GSH in PBS would take 
much longer time than the degradation by TCEP. Based on these 
results, we conclude that the as-synthesised CCS polymers were 
biodegradable.  75 
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Fig. 6 19F NMR spectra of the CCS polymers in PBS/D2O (90/10, v/v) with 20 mg/mL concentration at 25 oC.    
 
 
 5 
 
 
Fig. 7 Relaxation times of CCS-1 (A), CCS-2 (B) and CCS-3 (C) at 
different pH   
19F NMR study 10 
In order to assess their potential as pH-responsive 19F MRI 
contrast agents, the CCS polymers were examined by 19F NMR in 
solutions with different values of pH. As displayed in Fig. 6, only 
one peak at -72.6 ppm was observed in each spectrum of all the 
three samples, confirming a single 19F chemical environment in 15 
the CCS polymer structure. When the pH was raised, this peak 
became broader and the signal intensity decreased, as highlighted 
by the superimposed spectra in Fig. 6 (B), (D) and (F). As 
discussed above, the particle size was dependent on pH owing to 
the presence of the pH-sensitive monomer DMAEMA. An 20 
increase in pH leads to the deprotonation of PDMAEMA, thus 
the P(TFEMA-co-DMAEMA) block becomes hydrophobic and 
tends to aggregate in aqueous solution,  reducing the mobility of 
19F nuclei. This leads to an increase in the NMR line width and a 
decrease in the 19F signal intensity. In addition, it can be seen that 25 
the increase of 19F content (from CCS-1 to CCS-3) also resulted 
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in a considerable decrease in the signal intensity because of the 
increased likelihood of association of the 19F-containing 
segments. Overall, the 19F NMR results indicated that the 19F 
signal was dependent on both solution pH and 19F content. 
  Spin-lattice (T1) and spin-spin (T2) relaxations times were also 5 
measured at different values of pH. For CCS-1, the T2 first kept at 
around 35 ms below pH 6.5 and then dropped drastically to less 
than 5 ms at pH 8. The T2 at pH 9 could not be measured due to 
the greatly attenuated signal.  Meanwhile the T1 was not greatly 
affected by the change of pH, indicating that the spectral density 10 
of high MHz motions of the fluoroethyl segments is not greatly 
affected by the change in polymer dimensions. Similar 
conclusions were reached by Peng et al. in their study of the 
behaviour of linear block copolymers.23, 25 For CCS-2, the T2 was 
much lower than that of CCS-1, but it showed a similar behaviour 15 
with changes in pH. As before, the T2 above pH 7 could not be 
measured, demonstrating the reduced mobility of the 19F nuclei. 
The T2 of CCS-3 could not be measured at all values of pH owing 
to the self-association of 19F-containing units and highly 
restricted motion, but was instead estimated from the width of the 20 
lines in the NMR spectra. 
 
 
Fig. 8 In vitro 1H and 19F MRI images of the CCS polymers in solutions at four values of pH.
 25 
 
Fig. 9 Signal-to-noise ratio (SNR) of CCS-1 and CCS-2 at four pHs. 
 
 
In vitro 19F MRI evaluation  30 
Following the 19F NMR study, the CCS polymers were evaluated 
for in vitro 19F MRI. As depicted in Fig. 8, 1H RARE images 
were taken to allow localisation of the sample vials (phantoms). 
The 19F MR images are shown on the right-hand side of Fig. 8. 
CCS-1 and CCS-2 showed a clear change in imaging 35 
performance at the four values of pH. Specifically, CCS-1 could 
be well visualised at pH 5, and the intensity decreased upon an 
increase of pH until being undetectable at pH 8. The figure 
demonstrates that CCS-2 was detected at pH 5 and 6.5 with poor 
signal-to-noise, and exhibited no signal at pH 7.4 and 8. 40 
Unsurprisingly, CCS-3 could not be imaged at all values of pH 
owing to its very short T2 relaxation times. As shown in Fig. 9, a 
decrease in signal-to-noise ratio (SNR) was confirmed on an 
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increase in pH of the polymer solution. On the basis of this 19F 
MRI study, CCS-1 and CCS-2 showed better imaging 
performance at acidic pH. Thus it can be expected that these 
particles could be visualised only at acidic pH, and are thus 
potential candidates for the detection of tumour tissues that have 5 
acidic environments. 
  Our previous study of star polymers with fluorinated and 
DMAEMA units within the branched core also demonstrated a 
change in imaging performance with pH.52  However, the best 
performing polymer in this current work (CCS-1) exhibited much 10 
better imaging performance at a comparable 19F content. For this 
reason the MRI scan time could be notably shortened to 1 hour 8 
minutes from 9 hours 6 minutes. We hypothesise that this 
improvement is attributed to the greater flexibility of polymer 
chains around the core for the CCS polymer compared with the 15 
segments within the relatively confined core-crosslinked 
structure.  
Conclusions 
In conclusion, CCS polymers were synthesised by RAFT 
dispersion polymerisation through the arm-first approach. The 20 
synthetic conditions were studied and optimised. The as-
synthesised CCS polymer could form nanoparticles in aqueous 
solution and the particle size was dependent on pH. In addition, 
the CCS polymers were degradable due to the abundant disulfide 
bonds in the core. Moreover, 19F NMR confirmed that the 19F 25 
signal intensity was attenuated as the T2 relaxation time decreased 
upon an increase of pH of the polymer solution. In vitro 19F MRI 
indicated that the CCS polymers could be imaged well at acidic 
pH while they had poor imaging performance above 
physiological pH, demonstrating that these CCS polymers are 30 
promising 19F MRI contrast agents for the selective imaging of 
tumour tissues.   
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